Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06900725
PHASE2/PHASE3

Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke

Sponsor: National Taiwan University Hospital

View on ClinicalTrials.gov

Summary

This prospectively enrolled, pragmatic randomized trial aims to investigate whether very low dose edoxaban regimen (15 mg daily) achieves similar edoxaban concentrations as low dose edoxaban regimen (30 mg daily), while maintaining a comparable risk of clinical outcomes and reducing major bleeding in elderly patients with atrial fibrillation and a history of ischemic stroke or transient ischemic attack.

Official title: Low-Dose Edoxaban Versus Very-Low-Dose Edoxaban in Elderly Patients With Atrial Fibrillation and a History of Stroke (LEAVE-Stroke): A Pragmatic Randomized Clinical Trial

Key Details

Gender

All

Age Range

80 Years - Any

Study Type

INTERVENTIONAL

Enrollment

300

Start Date

2025-04-01

Completion Date

2030-12-31

Last Updated

2025-04-02

Healthy Volunteers

No

Interventions

DRUG

edoxaban

edoxaban 15 mg daily will be administered to the patients as secondary stroke prevention.

DRUG

Edoxaban 30 mg

edoxaban 30 mg daily will be administered to the patients as secondary stroke prevention.

Locations (1)

National Taiwan University Hospital

Taipei, Taiwan